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Introduction
Bone homeostasis is skillfully regulated through osteoclasts and 
osteoblasts. Aging induces a reduction in bone mass by decrease 
in osteoblactic bone formation and increase in osteoclastic bone 
resorption. Osteoporosis with its accompanying decrease in bone 
mass is widely recognized as a major public health problem. The 
most dramatic expression of  the disease is represented by frac-
tures of  the proximately femur, and the number of  which increas-
es as the population ages [1]-[3]. Malnutrition or undernutrition is 
often observed in the elderly, and it appears to be more intense in 
patients with hip fracture than in the general aging population [4]. 
Deficiency in both micronutrients and macronutrients appears to 
be strongly implicated in the pathogenesis and the consequences 
of  hip fracture in the osteoporotic elderly. 
There is growing evidence that nutritional factors have a role in 
the prevention of  bone loss with increasing age [5]-[7]. Food life 
may help to prevent bone loss with aging. Chemical compounds 
in food and plants, which regulate bone homeostasis, have been 
to be notice. Recent studies have been shown that nutritional and 
functional food factors, which are present in fruit and vegetables, 
stimulate osteoblastic bone formation and suppresses osteoclastic 
bone resorption in osteoporosis animal models and human sub-
jects [5]-[7], thereby increasing bone mass. Supplemental intake 
of  ingredients plays a role in maintaining of  bone health and in 
the prevention of  bone loss.
 This review introduces recent findings concerning the role of  
soybean genistein in the regulation of  bone homeostasis and in 
the prevention of  osteoporosis in animal models and human sub-
jects. 
Genistein stimulates osteoblastic bone formation 
Bone cells in bone homeostasis.   Bone homeostasis is regulated 
through the functions of  osteoblasts and osteoclasts, which are 
major cells in bone tissues [8]-[14]. Osteoblasts, which are dif-
ferentiated from bone marrow messenchymal stem cells, stimu-
late bone formation and calcification, while osteoclasts, which 
develop from hematopoietic progenitors, promote bone resorp-
tion. Osteoclasts are recruited to the site and excavate the calcified 
matrix. In the physiologic process of  bone turnover, a resorp-
tive stimulus firstly triggers recruitment of  osteoclasts to a site on 
the bone surface. After the resorbed lacunar pit is filled with new 
osteoid, osteoblasts become flatter and less active, with the final 
newly remodeled bone surface lined by flat lining cells. Remod-
eling of  cancellous bone begins with the retraction of  lining cells 
that cover the bone surface [13]. 
Bone acts as major storage site for growth factors, which are pro-
duced by osteoblasts, diffuse into newly deposited osteoid and 
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are stored in the bone matrix including isulin-like growth fac-
tors (IGF- I and II), transforming growth factor-β1 (TGF-β1), 
platelet-derived growth factor (PDGF), or bone morphologic 
proteins (BMPs) [12]-[14]. These bone-derived factors, which can 
be liberated during subsequent periods of  bone resorption, act in 
an autocrine, paracrine, or delayed paracrine fashion in the local 
microenvironment of  the bone surface. The process of  bone re-
modeling to make bone is unique among organs and tissues, and 
it is complexity with respect to interactions along the remodeling 
sequence by systemic influences (hormones), stress action on tra-
becular and cortical systems, growth factors and cytokines pro-
duced by the bone cells which act locally on their own cell types 
and on the other bone cell types, or factors that come from nearby 
cells present in the bone marrow tissues. Functional food factors 
may have a regulatory effect on the process of  bone remodeling.
Genistein has an anabolic effect in bone tissues.  Isoflavones (in-
cluding daidzin, daidzein, genistein, and genistein) are contained 
in soybeans with relatively high concentrations. Daidzin or genis-
tin is hydrolyzed to daidzein or genistein by β-glucosidase in the 
gastrointestinal system, respectively. Genistein has been found to 
have a strong inhibitory effect on protein tyrosine kinase and it 
can cause cell cycle arrest and apotosis in leukemic cells [15]. This 
cellular mechanism of  genistein may be important in the preven-
tion of  cancers. Yamaguchi et al.found that genistein or daidzein 
has been demonstrated to have a direct anabolic effect on bone 
metabolism in vitro [16], suggesting a role in the prevention of  os-
teoporosis. This was the first time finding. Genistein as a food fac-
tor is usefulness in the prevention and treetment of  osteoporosis.
The anabolic effects of  genistein on bone metabolism have 
been demonstrated in tissue culture using the femoral metaphy-
seal (trabecular bone) tissues obtained from elderly female rats 
in vitro [16],[17]. Bone tissues were cultured for 24 hours in a 
Dulbecco’s modified Eagle’s medium (high glucose, 4.5%) with 
bovine serum albumin (serum free) containing either vehicle or 
genistein. The presence of  genistein (10-6 or 10-5 M) caused a sig-
nificant increase in bone components  (cal cium content, alkaline 
phosphatase activity, and DNA content) in rat femoral metaphy-
seal tissues [16],[17]. The effect of  genistein in increasing bone 
components is equal to the stimulatory effects of  17β-estradiol, 
which is important anabolic hormone in bone metabolism. Anti-
estrogen agent tamoxifen inhibited the genistein-induced increase 
in bone components, although tamoxifen itself  had no effect 
on bone components [16]. The anabolic effects of  genistein on 
bone metabolism may be partly mediated through etrogen-like 
action. Presumably, genistein binds to the receptor of  estro-
gen in osteoblastic cells in which the receptor is localized [18]. 
The effects of  genistein or genistin on bone components have 
been compared in an in vitro culture system [16]. Culture with 
genistein (10-8 - 10-5 M) or genistin (10-7 - 10-5 M) increased alka-
line phosphatase activity and deoxyribonucleic acid (DNA) and 
calcium contents in the femoral-metaphyseal tissues obtained 
from elderly female rats [16]. The effect of  genistein was greater 
than that of  genistin. The effects of  genistein or genistin in in-
creasing bone components were blocked in the presence of  cy-
cloheximide, an inhibitor of  protein synthesis in the translational 
process, suggesting that the anabolic effects of  the isoflavones 
are partly resulted from newly synthesized protein components.
The anabolic effects of  daizein on the femoral-diaphyseal (corti-
cal bone) tissues obtained from elderly female rats in vitro have 
also been shown [19]. The presence of  daidzein (10-6 or 10-5 M) in 
culture medium caused a significant increase in bone components. 
The effect of  daizein was equal to that of  genistein (10-6 or 10-5 
M). The combination of  daidzein and genistein did not have an 
additive effect [19]. In addition, the stimulating effect of  daidzein 
on bone components was completely suppressed in the presence 
of  cycloheximide [19], suggesting that its effect is resulted from 
protein synthsis.
 
The effects of  phosphogenistein and phosphodaidzein, which 
are phosphorylated for the hydroxyl group at the 7-position of  
genistein and daidzein, on bone components has been compared 
to the effect of  genistein or daizen [20]. Phosphogenistein or 
phosphodaidzein increased bone components in tissue culture in 
vitro. Phosphoisoflavones with a lower concentration of  10-6 M, 
at which genistein and daidzein have anabolic effects on bone 
components, did not have an effect [20].
 
The effects of  various polyphenols found in food and plants 
on bone metabolism have also been compared [21]. Gly-
citein, resveratol, quercetin, catechin, and (-)-epigallocat-
echin gallate did not have an anabolic effect on bone cal-
cification in vitro [21]. Polyphenols did not have a direct 
stimulative effect on bone calcification in vitro. Among various 
polyphenol, genistein has a unique anabolic effect on bone. 
As the mentioned above, genistein is a 4’, 5, 7-trihydroxyisofla-
vone, and daidzein is a 4’, 7-dihydroxyisoflavone. Glycitein is a 
4’, 7-dihydroxy-6-methoxyflavone, while quercetin is a 3, 3’, 4’, 5, 
7-pontahydeoxyflavone; neither has any effect of  genistein and 
daidzein on bone calcification is weakened by the phosphoryla-
tion of  the hydroxy-group at their-7-position [21]. The hydroxy-
groups at the 5- and 7-positions of  the isoflavone genistein may 
be necessary for its anabolic effect on bone formation, suggesting 
a chemical structure-activity relationship. Presumably, the chemi-
cal form of  dihydroxyisoflavone is important in revealing its ana-
bolic effects on bone. Genistein and daidzein may have bone ef-
fect that operates via the same mechanism.
Genistein stimulates osteoblastogenesis.  Osteoblasts play an es-
sential role in the stimulation of  bone formation and calcifica-
tion. The anabolic effect of  isoflavones on osteoblastic cells in 
vitro has been demonstrated [22-24]. Osteoblastic MC3T3-E1 
cells were cultured for 48 hours in a serum-free modified Eagle’s 
medium containing genistein or daidzein. The presence of  gen-
istein (10-6 or 10-5 M) or daidzein (10-6 or 10-5 M) caused a signifi-
cant increase in protein content, alkaline phosphatase activity and 
DNA content in the cells [22]. The ability of  genistein or daidzein 
to increase biochemical components in the cells was not seen in 
the presence of  an inhibitor of  protein synthesis [22], suggesting 
that the effects of  isoflavones result from newly synthesized pro-
tein components. The anabolic effects of  genistein in osteoblastic 
cells are not distinguishable from those of  daidzein [22,23].
The effects of  17β-estradiol in increasing protein content and al-
kaline phosphatase activity in osteoblastic cells were not enhanced 
in the presence of  genistein [22]. Cellular protein content was ad-
ditively increased with 17β-estradiol and daidzein, but their effects 
on alkaline phosphatase activity were not additively. The receptors 
of  estrogen are found in osteoblastic cells. Genistein has been 
shown to bind to estrogen receptor β in osteoblastic cells [18], 
and daidzein cannot bind to the receptor [18]. It is speculated that 
genistein may bind to estrogen receptor β in osteoblastic cells, 
although the nuclear localization of  genistein in these cells has 
poorly understood.
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DNA content in osteoblastic cells was increased in the presence 
of  genistein or daizein, suggesting that isoflavones stimulate cell 
proliferation [22,23]. Isoflavones increase alkaline phosphatase 
activity, which is a marker enzyme in the differentiation of  os-
teoblastic cells. Genistein and daidzein may have the stimulatory 
effects on the proliferation and differentiation of  osteoblastic 
MC3T3-E1 cells.
The cellular mechanism by which isoflavones stimulate osteo-
blastic bone formation has been studied in relation to protein 
synthesis [24]. The presence of  genistein or daidzein stimulated 
protein synthesis in osteoblastic MC3T3-E1 cells in vitro [24]. 
The addition of  genistein or daidzein into the reaction mixture 
of  protein synthesis using the cell homogenate from osteoblas-
tic cells cultured without isoflavone caused a significant increase 
in protein synthesis in vitro [24]. This increase was suppressed in 
the presence of  an inhibitor of  protein synthesis, indicating that 
genistein or daidzein can directly stimulate protein synthesis in 
vitro. Moreover, genistein or daidzein has been shown to increase 
[3H]-leucyl-tRNA synthetase activity in the cytosol fraction of  
osteoblastic cell homogenate [24]. Genistein had a greater effect 
than daidzein [24]. Isoflavone can directly activate leucyl-tRNA 
synthetase, a rate-limiting enzyme in the translational process of  
protein synthesis.
The possibility that genistein or daidzein acts on the translational 
process in osteoblastic MC3T3-E1 cells cannot exclude, however, 
since the stimulating effects of  the isoflavones on protein syn-
thesis in osteoblastic cells are suppressed by actinomycin D, an 
inhibitor of  transcription activity [24]. Genistein has been shown 
to bind to estrogen receptors in osteoblastic cells [13], although 
daidzein cannot bind to estrogen receptors [18]. Moreover, it is 
possible that genistein or daidzein can bind to other transcrip-
tion factors, which differ from estrogen receptors, in osteoblastic 
MC3T3-E1 cells. 
The estrogenic compounds of  17β-estradiol and genistein me-
diate very different actions on osteoblastic cells [25]. While 
17β-estradiol may stimulate bone anabolism, in part, by antago-
nizing TNFα-induced NF-κB activation, genistein did not only 
fails to prevent the cytokin-induced NF-κB activation, but directly 
promotes NF-κB activation in MC3T3 cells [25]. These observa-
tions suggest an important mechanistic difference in the mecha-
nisms by which 17β-estradiol and genistein promote osteoblast 
differentiation [25]. Whether genistein has an effect on various 
protein kinases and protein phosphatases that are related to os-
teoblastic cell proliferation and nuclear transcription activity re-
mains to be elucidated.
Molecular mechanism by which genistein stimulates osteoblas-
togenesis.  The cellular and molecular mechanism by which gen-
istein enhances osteoblastogenesis has been examined [26,27]. 
Culture with genistein (10-5 M) has been found to have a stimula-
tive effect on the mineralization in osteoblastic cells in vitro [26]. 
Alkaline phosphatase is an enzyme marker of  osteoblasts and the 
enzyme participates in bone mineralization [27]. α1 (I) collagen is 
a matrix protein that is related to bone formation and mineraliza-
tion in osteoblast lineage cells [28]. Osteocalcin is a bone matrix 
protein containing γ2-carboxyglutamin acid, which is synthesized 
in osteoblasts and is protein involved in mineralization [28]. The 
expression of  alkaline phosphatase, α1 (I) collagen, and osteoc-
alcin mRNAs in osteoblastic cells was markedly enhanced after 
culture with genistein (10-6 or 10-5 M) as compared to the effect 
of  each factor [26].
 
The effect of  genistein (10-5 M) on the gene expression 
in osteoblastic cells was completely depressed in the pres-
ence of  cycloheximide, an inhibitor of  protein synthesis, and 
5,6-dichlorobenzimidazone-1-β-D-ribofuranoside (DRB), an 
inhibitor of  transcriptional activity [26]. This suggests that gen-
istein stimulates transcriptional process in osteoblastic cells. Gen-
istein may have a stimulative effect on protein synthesis at the 
transcriptional process. Genistein (10-6 or 10-5 M) was found to 
increase protein content in osteoblastic MC3T3-E1 cells in vitro 
[26]. This effect of  genistein may involve in the activation of  
aminoacyl-tRNA synthase, a rate-limiting enzyme in protein syn-
thesis. Genistein may stimulate both transcriptional and transla-
tional activities in osteoblastic cells. It is speculated that genistein 
has an effect on the binding of  transcriptional factor(s), which is 
synthesized through translational process, to the nuclear DNA in 
osteoblastic cells.
 
Genistein (10-6 M) has been shown to result in an increase in cell 
proliferation and stimulated osteoblastic maturation as assessed 
by culture duration-dependent increments in alkaline phosphatase 
activity, calcium deposition into extracellular matrix and Runx2/
Cbfa1 gene expression in primary mouse bone marrow-derived 
mesenchymal stem cells (BMSCs) cultures [29]. Genistein also re-
sulted in an increase in nitric oxide (NO) synthase activity, NO 
formation, and cyclic guanosine 3’, 5’-monophosphate produc-
tion in BM-SCs cultures [29]. These effects of  genistein were 
mimicked by 17β-estradiol [29].
Whether genistein and daidzein regulate target gene transcription 
through cyclic adenosine 3’, 5’-monophosphate (cAMP) regulato-
ry element (CRE) in human osteoblastic cell line MG-63 cells has 
been shown [30]. It was found that 17β-estradiol, genistein and 
daidzein suppressed the transcriptional activity of  CRE-luciferase 
reporter gene in MG-63 cells [30]. 17β-estradiol and genistein but 
not daidzein inhibited the cAMP analogue 8-Br cAMP-induced 
transcription of  CRE reporter gene [30]. Both genistein and 
17β-estradiol inhibited basal and cAMP-induced mRNA levels of  
endogenous estrogen responsive genes containing CRE/CRE-
like elements in their promoter regions, including interleukin (IL) 
8 and serum- and glucocorticoid-inducible kinase 1 [30]. These 
findings indicate that genistein and daidzein may modulate bone 
remodeling through ERs by regulating target gene expression 
through the CRE motifs.
     
Genistein suppresses osteoclastic bone resorp-
tion
Genistein suppresses bone resorption in bone tissues.  Parathy-
roid hormone (PTH), prostaglandin E2 (PGE2), and lipopolysac-
charide (LPS) have a stimulative effect on bone resorption in in 
vitro culture system [31-33]. Culture with PTH, PGE2, or LPS 
clearly stimulated bone resorption in the femoral-metaphyseal tis-
sues cultured for 48 hours, when bone resorption was estimated 
with a decrease in bone calcium content [34]. The effects of  bone-
resorbing factors were completely suppressed in the presence of  
genistein, indicating an inhibition of  bone resorption [34]. 
PTH and PGE2 caused a remarkable increase in glucose con-
sumption and lactic acid production by bone tissues [34]. The 
production of  lactic acid by bone tissues may be partly related 
to the augmentation of  glucose consumption. Presumably, PTH- 
and PGE2-stimulated lactic acid productions in bone tissues 
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hasten a decrease in bone calcium content. Genistein completely 
depressed the PTH- or PGE2-induced increase in both glucose 
consumption and lactic acid production in bone tissues [34]. The 
inhibitory effects of  genistein on bone resorption may be partly 
related to the prevention of  lactic acid production by bone tissues.
Thus, genistein has a stimulative effect on both bone formation 
and mineralization in tissue culture in vitro, and it has also been 
found to have a suppressive effect on bone resorption in tissue 
culture. Genistein may have an important role in the preservation 
of  bone mass.
Genistein suppresses osteoclastogenesis.   Osteoclasts, bone-re-
sorbing cells, are formed from bone marrow stem cells [10,11, 
,35]. Osteoclast-like cell formation is estimated using staining for 
tartrate-resistant acid phosphatase (TRACP), a marker enzyme 
of  osteoclasts [35]. Mouse bone marrow cells were cultured for 
7 days in a medium containing a bone-resorbing agent [PTH, 
PGE2, 1, 25-dihydroxyvitamin D3 (VD3), or LPS] with an effec-
tive concentration [36]. Culture with PTH, PGE2, VD3, or LPS 
induced a remarkable increase in osteoclast-like multinucleated 
cells. These increases were depressed in the presence of  genistein 
[36]. The suppressive effects of  genistein (10-5 M) were equal 
to the effects of  other anti-bone-resorbing agents (calcitonin, 
17β-estradiol, and zinc sulfate) on osteoclast-like cell formation 
in mouse marrow culture [36].
   
Genistein has been shown to have a potent suppressive effect at 
the later stage of  differentiation of  bone marrow cells [36]. The 
suppressive effect of  genistein on osteoclast-like MNC formation 
in mouse bone marrow culture was greater than that of  daidzein. 
The suppressive effect of  genistein on osteoclast-like MNC for-
mation induced by PTH or PGE2 may be partly based on the 
blocking of  the pathway of  cyclic AMP signaling, but not that 
by protein kinase C signaling, at the differentiation stage of  bone 
marrow cells [36]. In addition, if  genistein can inhibit tyrosine 
kinase [15], the action of  isoflavone on osteoclastic cell forma-
tion may be partly related to its inhibitory effect on the kinase. 
The cellular mechanism by which genistein inhibits osteoclast-like 
cell formation from marrow cells may also be involved in cyclic 
AMP signaling.
Interleukin-6 (IL-6) has been known to stimulate osteoclastogen-
esis and osteoprotegerin (OPG) depress binding of  RANKL to 
RANK, which is receptor protein of  RANKL [10]. These fac-
tors are produced in osteoblastic cells [10].  OPG mRNA expres-
sion has been found to increase in osteoblastic cells treated with 
17β-estradiol, genistein, or daidzein [37]. The release of  IL-6 in 
the cells was suppressed, while OPG production was enhanced 
by isoflavone treatments [37]. After adding the estrogen receptor-
binding blocker, ICI-182780, the effects of  isoflavones on OPG 
and IL-6 production disappeared [37] Thus, the inhibition by di-
etary isoflavones of  IL-6 production and the stimulation of  OPG 
appear to be mediated, at least in part, via a genomic pathway 
operating through estrogen receptors and gene expression mech-
anisms [37]. The stimulation of  OPG mRNA levels by genistein 
was not affected by the protein synthesis inhibitor, cycloheximide 
and was shown to be due to enhancement of  OPG gene tran-
scription [38]. Thus, genistein may partly suppress bone resorp-
tion and bone loss by enhanced osteoblastic production of  OPG. 
RANKL or tumor necrosis factor-α (TNF-α) have been shown to 
stimulate osteoclastic differentiation using RAW264.7, a murine 
monocytic cell line. The direct effects of  estrogen on osteoclast 
precursor differentiation has been shown that, in addition to ef-
fecting osteoblasts, estrogen may protect bone by reducing osteo-
clast production [39]. Both genistein and estrogen has been found 
to inhibit RANKL-induced IkappaB degradation and NF-kappaB 
(NF-κB) nuclear localization, which is a intracellular signaling fac-
tor of  RANKL, with the same relative potency as seen in prolif-
eration and differentiation assays [39]. Genistein has been shown 
to depress TNF-α-induced c-fos and NFATc1 expressions in an 
estrogen receptor-dependent manner and also inhibit NFATc1 
nuclear translocation [40]. This finding suggests that phytoestro-
gens suppress TNF-α-induced osteoclastogenesis via inhibition 
of  c-fos-dependent NFATc1 expression [40]. 
Action of  genistein in mature osteoclasts.  Genistein has been 
found to induce cell death (apoptosis) of  osteoclasts isolated 
from rat femoral tissues [41,42]. Calcitonin has been known to 
inhibit osteoclast activity [43]. This hormonal effect may be medi-
ated through the two pathways of  cyclic AMP and Ca2+ signalings 
[49]. The addition of  dibucaine, an antagonist of  calmodulin, or 
staurosporine, an inhibitor of  pretin kinase C, completely pre-
vented the decrease in osteoclasts induced by calcitonin, DcAMP, 
or calcium chloride [41]. The effect of  genistein in decreasing 
osteoclasts was clearly suppressed by these inhibitors, suggesting 
that the effect of  isoflavones on mature osteoclasts is partly medi-
ated through the pathway of  Ca2+ signaling.
A Ca2+ ionophore (A23187) caused a remarkable decrease in the 
number of  osteoclasts, indicating that the entry of  Ca2+ in the 
cells induces death of  osteoclasts [44]. The number of  osteoclasts 
was decreased, when were cultured in the presene of  genistein or 
calcium chloride. Ca2+ can activate endonuclease and the metal in-
duces apoptosis in cells [45]. The effect of  A23187 in decreasing 
osteoclasts may be based on Ca2+-activated DNA fragmentation, 
which induces apoptosis. Genistein has been shown to induce 
apoptosis in immature human thymocytes by inhibiting torosi-
somerase II [46].
  
Genistein may stimulate apoptosis of  osteoclasts, and its mecha-
nism is partly related to the pathway of  Ca2+ signaling. It is pos-
sible that genistein stimulates Ca2+ entry into osteoclasts, since it 
has been reported that the isoflavone can directly open a chloride 
channel in human cystic fibrosis transmembranes [41]. In addi-
tion, daidzein has also been shown to suppress the number of  
mature osteoclasts [41], although daidzein did not have a greater 
suppressive effect than genistein. The effect of  daidzein was abol-
ished in the presence of  dibucaine or staurosporine, supporting a 
partial involvement in the Ca2+-signaling mechanism [41].
Culture with genistein has been found to cause an inhibition of  
protein kinase activity and an appreciable elevation of  protein 
tyrosine phosphatase activity in osteoclasts [42]. Genistein has a 
strong inhibitory effect on protein tyrosine kinases [15]. The inhi-
bition of  these kinases may induce apoptosis in a human ovarian 
tumor cell line and in Jurket T-leukemia cells [15]. Genistein may 
partly induce apoptosis of  osteoclasts through a mechanism that 
inhibits protein tyrosine kinases in the cells. It has been shown 
that tyrosine kinase Src is implicated in the process of  osteoclast-
induced bone resorption in vitro and in vivo [47].
Culture with genistein has also been found to cause a significant 
increase in protein tyrosine phosphatase activity in osteoclasts 
[42]. This effect was also seen after the addition of  genistein into 
the enzyme reaction mixture in vitro [42]. Genistein can directly 
activate protein tyrosine phosphatase in osteoclasts. Vanadate is 
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an inhibitor of  protein tyrosine phosphatase [48]. Culture of  os-
teoclasts in the presence of  vanadate did not cause a decrease in 
the number of  osteoclasts. The suppressive effect of  genistein on 
osteoclasts was also seen in the presence of  vanadate [42]. It has 
been known that protein tyrosine phosphatase (Src homology 2 
domain-containing tyrosine phosphatase) is a negative regulator 
of  osteoclastogenesis and osteoclast-resorbing activity in mutant 
mice [49]. The suppressive effect of  genistein on mature osteo-
clasts may partly be mediated through the activation of  protein 
tyrosine phosphatase in the cells.
β-Glucuronidase is a lysomal enzyme, which is involved in the 
stimulation of  bone resorption by PTH. Genistein did not have 
an effect on β-glucuronidase activity in osteoclasts [42]. The sup-
pressive effects of  genistein on osteoclastic bone resorption may 
not be implicated in the activity of  lysosomal enzymes in the cells.
Thus, the suppressive effects of  genistein on rat bone osteoclasts 
may be involved in cell apoptosis mediated through the Ca2+ siga-
naling mechanism, inhibition of  protein kinase, and activation of  
protein tyrosine phosphatase in the cells.
Genistein regulates gene expression in osteoclasts.  Genistein 
has been shown to regulate the gene expression of  proteins that 
are related to osteoclast function. Culture with genistein (10-6 M) 
caused an increase in DNA fragmentation in isolated osteoclastic 
cells [50], indicating that genistein stimulates apoptotic cell death. 
In addition, the genistein-induced cell death was significantly pre-
vented in the presence of  caspase-3 inhibitor [50]. However, this 
effect was partial. Apoptotic cell death with genistein is partly 
mediated through activation of  caspase-3, and also other mech-
anisms may participate in apoptotic cell death. The stimulatory 
effect of  genistein (10-6 M) on the caspase-3 mRNA expression 
was completely suppressed after culture with cycloheximide, an 
inhibitor of  protein synthesis, or DRB, an inhibitor of  transcrip-
tional activity, in osteoclastic cells with or without macrophage 
colony stimulating factor (M-CSF) and RANKL [50]. This finding 
suggests that the effect of  genistein on caspase-3 mRNA expres-
sion is involved in protein synthesis and transcription activation 
in osteoclastic cells.
 
The RANK activation by binding of  RANKL on preosteoclasts 
stimulates the NF-κB signaling, propbably through association 
with TRAF-6 in osteoclasts [51,52]. RANKL signaling targets in-
clude mitogen-activated protein kinases (MAPKs), NF-κB, and 
nuclear factor of  activated T cells c1 (NFATc1) in osteoclast 
differentiation [51,52]. Culture with genistein (10-6 M) did not 
cause a significant change in NF-κB mRNA expression in osteo-
clastic cells in the presence or absence of  M-CSF and RANKL 
[44]. NFATc1 mRNA expression was significantly increased af-
ter culture with genistein (10-6 M) in osteoclastic cells cultured in 
the presence of  M-CSF and RANKL [50]. Genistein may affect 
on the gene expression of  NFATc1 that is a target protein of  
RANKL signaling in osteoclastic cells. The decrease in NFATc1 
expression with the combination of  genistein may be important 
in the revelation of  the suppressive effect on osteoclastogenesis 
and osteoclastic cell function.
The activation of  TRACP or cathepsin K plays a role in the pro-
motion of  osteoclastic bone resorption by stimulating the decom-
position of  bone matrix [50]. Genistein (10-6 M) did not have a 
significant effect on TRACP mRNA expression in osteoclastic 
cells [50]. Culture with genistein was found to induce a signifi-
cant decrease in cathepsin K mRNA expression in osteoclastic 
cells cultured in the presence or absence of  M-CSF and RANKL 
[50]. This finding demonstrates that genistein (10-6 M) has a sup-
pressive effect on the activity of  cathepsin K in osteoclastic cells, 
which are activated through RANKL signaling. Genistein has a 
potent suppressive effect on bone-resorbing activity.
 
Intake of  dietary soybean genistein  prevents osteoporosis 
in animal model  
Bone mass decreases with age. Osteoporosis with a decrease in 
bone mass is widely recognized as a major public health prob-
lem. This decrease may be due to increased osteoclastic bone re-
sorption and to decreased osteoblastic bone formation. Soybean 
genistein has been found to stimulate osteoblastic bone forma-
tion and inhibit osteoclastic bone resorption as shown in Figure 
1. Whether the intake of  dietary soybean genistein can reveal an 
anabolic effect on bone in vivo has been examined.
Nijiru, which is a by-product in the fermentation process of  soy-
bean to make fermented soybean (natto), contains large quantities 
of  natural isoflavone [53]. Nijiru may be a functional food factor 
as a dietary isoflavone. The oral administration of  the isoflavone-
containing soybean extract (Nijiru) to rats caused a significant in-
crease in bone components (alkaline phosphatase activity, DNA 
and calcium contents) in the femoral-diaphyseal and -metaphyseal 
tissues in vivo [53], indicating the extract has an anabolic effect on 
bone metabolism. Also, Nijiru largely contains soybean saponin 
[54]. In addition, saponin has been shown to have a significant 
anabolic effect on bone components in the femoral tissues of  
rats [54]. 
Ovarian hormone deficiency at menopause stimulates bone loss. 
Ovariectomy (OVX) causes a lack of  estrogen, and the hormone 
deficiency induces osteoporosis in humans [1-3]. Bone weight, 
bone mineral density, and bone mineral content were reduced in 
OVX rats [55]. The prolonged intake of  fermented soybean diets 
with supplementation of  isoflavone and saponin has been dem-
onstrated to prevent bone loss in OVX rats [55], indicating that 
OVX-induced bone loss is prevented after the prolonged intake 
of  dietary isoflavone and saponin supplementation.
The fermented soybeans are food sources that largely contain 
genistein. The effect of  experimental diets using the fermented 
soybeans containing genistein on OVX-induced bone loss has 
also been demonstrated [56]. Experimental diets containing 44.6 
to 92.4 mg of  isoflavones (including genistein, genistein, daidzein, 
and daidzein) per 100 g of  diet was fed to OVX rats for 3 months. 
OVX caused a significant reduction in the dry weight, mineral 
density, calcium content, and alkaline phosphatase activity in the 
femoral tissues [56]. These reductions were prevented after feed-
ing a natto diet [56]. Thus, the prolonged intake of  dietary natto 
supplemented with isoflavone has a preventive effect on OVX-
induced bone loss, suggesting that it may have a role in the pre-
vention of  osteoporosis.
The effect of  a standardized soy extract (SSE, Soyselect) in the 
OVX rat model of  menopause has also been examined [57]. OVX 
rats were orally treated for 6 weeks with the soy extract (50 or 100 
mg/kg/day), vehicle (distilled water), or 17β-estradiol (0.5 mg/
kg/day) [57]. The SSE produced a bone-sparing effect associated 
with a slowing down in the increased bone turnover observed 
after OVX (as indicated by measurements of  serum osteocalcin 
levels and excretion ratio of  deoxypyridinoline) [57]. Remarkably, 
organ weight data and histopathologic analysis did not show any 
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stimulatory activity of  the SSE on the uterus [57]. Immunohisto-
chemical analysis showed a significant down-regulation of  estro-
gen receptor-α in uterine epithelium after 17β-estradiol treatment, 
but not after treatment with the SSE [57]. After treatment with 
17β-estradiol, estrogen receptor-β expression was not modulated 
in the stroma or epithelium, whereas the SSE induced an up-reg-
ulation of  estrogen receptor-β stromal expression [57]. Collec-
tively, these findings suggest that the lack of  stimulatory activity 
on the uterine epithelium using soy treatment could be due to a 
negligible stimulatory activity on estrogen receptor-α and/or to 
the enhanced expression observed in stromal estrogen receptor-β, 
the latter being considered as a negative modulator of  estrogen 
receptor-α-mediated uterine proliferation. Uterine epithelial pro-
gesterone receptor was down-regulated by 17β-estradiol, but not 
the SSE, as compared with that in OVX rats [57]. The minor in-
crease in lipid levels induced by OVX was not affected by SSE 
administration [57]. Thus, it has been demonstrated that the test-
ed extract has an interesting profile of  tissue-specific response, 
in that it is efficacious in preventing experimental osteoporosis 
without causing stimulation in uterus at doses that are effective 
in bone.
Preventive effect of  dietary soybean genistein on 
osteoporosis in human subjects
Twelve volunteers (six men and six women) were received Nijiru 
twice a day for 60 days at a dose of  1500 mg (6 tablets) per day 
[58]. The serum γ-carboxylated osteocalcin concentration, which 
is a marker of  osteoblastic bone formation, was significantly in-
creased after the intake of  Nijiru in both men and women to about 
2-fold that in the control group [58]. The intake of  isoflavone- 
and saponin-containing Nijiru stimulated the γ-carboxylation of  
osteocalcin, which plays an important role in osteoblastic bone 
formation and mineralization, in healthy individuals [58]. The di-
etary intake of  foods including genistein may have a role in the 
prevention of  osteoporosis in human subjects.
Change in circulating biochemical markers of  bone metabolism 
in aged individuals with the intake of  fermented soybean (natto), 
which was made from isoflavone-rich soybean, has been exam-
ined [59]. Sixty-three volunteers (31 men and 32 women) were 
divided into four groups of  15 or 16 male volunteers and 16 or 
16 female volunteers, and each group was sequentially given natto 
(40 g pack) containing once a day for 4 or 8 weeks as follows: 
either regular natto with naturally occuring isoflavone 35.0 mg 
and calcium 51.4 mg or supplemented natto containing isoflavone 
35.0 mg and calcium 60.0 mg. 
As serum bone markers, bone-specific alkaline phosphatase, 
γ-carboxylated osteocalcin, bone tartrate-resistant acid phos-
phatase (TRACP), and N-telopeptide of  type I collagen were as-
sayed. The intake of  regular natto for 4 or 8 weeks in men or 
women persons caused a significant increase in γ-carboxylated 
osteocalcin, a marker of  bone formation, and a significant de-
crease in serum bone N-teleopeptide of  type I collagen, a marker 
of  bone resorption, as compared with the value before intake 
[59]. Moreover, the intake of  natto for 8 weeks in men or women 
caused a significant increase in serum bone-specific alkaline phos-
phatase activity and γ-carboxylated osteocalcin concentration and 
a significant decrease in serum bone TRACP activity and N-telo-
peptide of  type I collagen, as compared with the values with the 
intake of  regular natto [59]. This study suggests that the intake of  
regular natto with isoflavone-rich soybean has a stimulatory effect 
on bone formation and the suppressive effect on bone resorption 
in aged individuals. 








Figure 1: Role of  genistein in bone homeostasis. Genistein stimulates osteoblastic bone formation and suppresses osteoclas-
tic bone resorption, thereby increasing bone mass. Genistein stimulates protein synthesis and proliferation of  osteoblastic 
cells, and it suppresses osteoclasogenesis from bone marrow stem cells and induces apoptosis of  mature osteoclasts.  Gen-
istein regulates bone homeostasis through independent and dependent mechanisms on estrogen receptors. Genistein regu-
lates the gene expression of  many proteins that are related to osteoblastic bone formation and osteoclastic bone resorption.
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 The prolonged intake of  dietary genistein may be usefulness for 
bone health and the prevention of  bone loss with aging and vari-
ous pathophysiolocal states.
Conclusion
Bone homeostasis, which is regulated through osteoblastic cells 
and osteoclastic cells in bone tissues, is disordered with aging and 
pathophysiologic state including menopause. This leads to bone 
loss, which may be due to decreased osteoblastic bone formation 
and increased osteoclastic bone resorption. Bone loss induces 
bone fracture, which is a public problem. Functional food factors 
may help to prevent bone loss with aging. This may be impor-
tant in maintaining bone health in long life. Genistein has been 
demonstrated to stimulate osteoblastic bone formation and to 
suppress osteoclastic bone resorption. The fermented soybeans 
(natto) are good food sources that largely contain genistein. The 
dietary fermented soybean intake has a preventive effect in the 
prevention and treatment of  bone loss in animal models and hu-
mans.  Moreover, the prevention of  bone fracture with dietary 
fermented soybean intake is supported through epidemiologic 
investigation in Japan. Interestingly, soybean richly contains zinc, 
an essential trace element, which reveals a stimulative effect on 
bone formation and a suppressive effect on bone resorption [6]. 
Combination with genistein and zinc has been shown to reveal a 
synergistic-anabolic effect on bone mass [60]. The composition 
of  genistein and zinc, which is named as Fosteum, has been devel-
oped as a novel supplement. This biomedical food factor has been 
demonstrated to be usefulness in the prevention and treatment of  
osteoporosis in human subjects.
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